SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008815
Filing Date
2023-05-09
Accepted
2023-05-09 16:08:45
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q olma-20230331x10q.htm   iXBRL 10-Q 1594125
2 EX-10.1 olma-20230331xex10d1.htm EX-10.1 364944
3 EX-10.2 olma-20230331xex10d2.htm EX-10.2 54115
4 EX-10.3 olma-20230331xex10d3.htm EX-10.3 60206
5 EX-31.1 olma-20230331xex31d1.htm EX-31.1 13576
6 EX-31.2 olma-20230331xex31d2.htm EX-31.2 13351
7 EX-32.1 olma-20230331xex32d1.htm EX-32.1 10437
8 GRAPHIC olma-20230331xex10d1001.jpg GRAPHIC 4013
  Complete submission text file 0001558370-23-008815.txt   6465636

Data Files

Seq Description Document Type Size
9 EX-101.SCH olma-20230331.xsd EX-101.SCH 35329
10 EX-101.CAL olma-20230331_cal.xml EX-101.CAL 46783
11 EX-101.DEF olma-20230331_def.xml EX-101.DEF 115972
12 EX-101.LAB olma-20230331_lab.xml EX-101.LAB 366771
13 EX-101.PRE olma-20230331_pre.xml EX-101.PRE 265741
61 EXTRACTED XBRL INSTANCE DOCUMENT olma-20230331x10q_htm.xml XML 909867
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39712 | Film No.: 23902016
SIC: 2834 Pharmaceutical Preparations